Skip to main content
SpringerLink
Log in
Book cover

Clinically Oriented Pulmonary Imaging pp 29–39Cite as

Lung Cancer

  • Chapter
  • First Online:

  • 2146 Accesses

Part of the book series: Respiratory Medicine ((RM))

Abstract

As the most common type of malignancy, lung cancer is regularly encountered by primary care physicians, pulmonologists, as well as radiologists during their routine practice. Many lung cancers are detected incidentally or when patients present with symptoms related to either local or systemic effects of a tumor. Imaging plays an important role in lung cancer staging through the characterization of the primary tumor, evaluation of nodal disease, and the detection of distant metastases. Imaging guidance can also provide a means for obtaining tissue diagnosis, both for the primary or metastatic lesions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. American Cancer Society. What are the key statistics about lung cancer? 2000. http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-key-statistics. Accessed 6 June 2011.

  2. American College of Radiology Appropriateness Criteria. Clinical condition: solitary pulmonary nodule. 2011. http://acsearch.acr.org/TopicList.aspx?topic_all=&topic_any=‘%22lung+cancer*%22’&connector=+And+&cid=0. Accessed 6 June 2011.

  3. Lowe VJ, Hoffman JM, DeLong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994;35:1771–6.

    PubMed  CAS  Google Scholar 

  4. Turkington TG, Adams MC, Wilson JM, Wong TZ. A systematic review of factors affecting accuracy of SUV measurements. Am J Roentgenol. 2010;195:310–20.

    Article  Google Scholar 

  5. Troung MT, Viswanathan C, Erasmus JJ. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging. 2011;26:132–46.

    Article  Google Scholar 

  6. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd ed.). Chest. 2007;132:108S–130S. http://chestjournal.chestpubs.org/content/132/3_suppl/108S.full. Accessed 6 June 2011.

    Google Scholar 

  7. Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest. 2007;132:131S–148S. http://chestjournal.chestpubs.org/content/132/3_suppl/131S.full. Accessed June 6 2011.

    Google Scholar 

  8. American Cancer Society Guidelines for the early detection of cancer. http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer. Accessed 6 June 2011.

  9. Fontana R, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med. 1986;28:746–50.

    Article  PubMed  CAS  Google Scholar 

  10. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984;130:561–5.

    PubMed  CAS  Google Scholar 

  11. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer. 1991;67:1155S–64S.

    Article  Google Scholar 

  12. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo lung project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308–16.

    Article  PubMed  CAS  Google Scholar 

  13. Berlin N. Overview of the NCI cooperative early lung cancer detection program. Cancer. 2000;89:2349S–51S.

    Article  Google Scholar 

  14. Kubik A, Polak J. Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer. 1986;57:2427–37.

    Article  PubMed  CAS  Google Scholar 

  15. Kubik AK, Parkin DM, Zatloukal P. Czech Study on Lung cancer screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89:2363S–8S.

    Article  Google Scholar 

  16. Frost J, Ball WC, Levin M, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130:549–54.

    PubMed  CAS  Google Scholar 

  17. Tockman MS. Survival and mortality from lung cancer in a screened population: the Johns Hopkins study. Chest. 1986;89:324S–5S.

    Article  Google Scholar 

  18. Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer. 2000;89:2356S–62S.

    Article  Google Scholar 

  19. Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: AACP evidence-based clinical practice guidelines (2nd ed.). Chest 2007;132:69S–77S. http://chestjournal.chestpubs.org/content/132/3_suppl/69S.long. Accessed 6 June 2011.

    Google Scholar 

  20. Henschke CI, Yankelevitz DF, Libby DM, et al. International early lung cancer action program investigators. survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–71.

    Article  PubMed  Google Scholar 

  21. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953–61.

    Article  PubMed  CAS  Google Scholar 

  22. Swenson S, Aberle D, Kazerooni EA, et al. Consensus statement: CT screening for lung cancer. J Thorac Imaging. 2005;20:321.

    Google Scholar 

  23. National Cancer Institute. Lung cancer trial results show mortality benefit with low-dose CT: twenty percent fewer lung cancer deaths seen among those who were screened with low-dose spiral CT than with chest X-ray. http://www.cancer.gov/newscenter/pressreleases/2010/NLSTresultsRelease. Accessed 6 June 2011.

  24. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  Google Scholar 

  25. White CS. National lung cancer screening trial: a breakthrough in lung cancer screening? J Thorac Imaging. 2011;26:86–7.

    Article  PubMed  Google Scholar 

  26. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. SeminRoentgenol. 2005;40:90–7.

    Google Scholar 

  27. Kodama T, Shimosato Y, Koide T, et al. Endobronchial polypoid adenocarcinoma of the lung: histopathological and ultrastructural studies of five cases. Am J Surg Pathol. 1984;8:845–54.

    Article  PubMed  CAS  Google Scholar 

  28. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thoracic Oncol. 2011;6:244–85.

    Article  Google Scholar 

  29. Koss M, Travis W, Muran C, et al. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol. 1992;9:117–23.

    PubMed  CAS  Google Scholar 

  30. Kondo T, Yamada K, Noda K, et al. Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas. Lung Cancer. 2002;36:49–57.

    Article  PubMed  Google Scholar 

  31. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients. Lung Cancer. 2002;36:289–95.

    Article  PubMed  Google Scholar 

  32. Nagao M, Murase K, Yasuhara Y, et al. Measurement of localized ground glass attenuation on thin-section computed tomography: correlation with progression of bronchioloalveolar cell carcinoma of the lung. Invest Radiol. 2002;37:692–7.

    Article  PubMed  Google Scholar 

  33. Colby T, Koss M, Travis WD. Tumors of the lower respiratory tract. 3rd ed. Washington: Armed Forces Institute of Pathology; 1995.

    Google Scholar 

  34. Soga J, Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1, 875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999;5:211–9.

    PubMed  CAS  Google Scholar 

  35. Union Internationale Contre le Cancer. TNM classification of malignant tumors. 7th ed. New York: Wiley-Blackwell; 2009.

    Google Scholar 

  36. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15:4–9.

    PubMed  Google Scholar 

  37. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260–71.

    Article  PubMed  Google Scholar 

  38. Kligerman S, Abbott G. A radiologic review of the new TNM classification for lung cancer. Am J Roentgenol. 2010;194:562–73.

    Article  Google Scholar 

  39. Greaves SM, Brown K, Garon EB, Garon BL. The new staging system for lung cancer imaging and clinical implications. J Thorac Imaging. 2011;26:119–31.

    Article  PubMed  Google Scholar 

  40. Suzuki C, Jacobsson H, Hatschek T, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics. 2008;329–344.

    Google Scholar 

  41. Gdeedo A, VanSchil P, Corthouts B, VanMieghem F, VanMeerbeeck J, VanMarck E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg. 1997;12:224–7.

    Article  PubMed  CAS  Google Scholar 

  42. Glazer H, Duncan-Meyer J, Aronberg D. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology. 1985;157:191–4.

    PubMed  CAS  Google Scholar 

  43. Pennes D, Glazer G, Wimbish K, Gross B, Long R, Orringer M. Chest wall invasion by lung cancer: limitations of CT evaluation. Am J Roentgenol. 1985;144:507–11.

    CAS  Google Scholar 

  44. Ratto G, Piacenza G, Frola C. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg. 1991;51:182–8.

    Article  PubMed  CAS  Google Scholar 

  45. Venuta F, Rendina E, Ciriaco P. Computed tomography for preoperative assessment of T3 and T4 bronchogenic carcinoma. Eur J Cardiothorac Surg. 1992;6:238–41.

    Article  PubMed  CAS  Google Scholar 

  46. Rendina E, Bognolo D, Mineo T. Computed tomography for the evaluation of intrathoracic invasion by lung cancer. J Thorac Cardiovasc Surg. 1987;94:57–63.

    PubMed  CAS  Google Scholar 

  47. Pearlberg JL, Sandler MA, Beute GH, Lewis JW Jr, Madrazo BL. Limitations of CT in evaluation of neoplasms involving chest wall. J Comput Assist Tomogr. 1987;11:290–3.

    Article  PubMed  CAS  Google Scholar 

  48. Gefter W. Magnetic resonance imaging in the evaluation of lung cancer. Semin RoentgenoI. 1990;25:73–84.

    Article  CAS  Google Scholar 

  49. Webb W, Sostman H. MR imaging of thoracic disease: clinical uses. Radiology. 1992;182:621–30.

    PubMed  CAS  Google Scholar 

  50. Castagno A, Shuman W. MR imaging in clinically suspected brachial plexus tumor. Am J Roentgenol. 1987;149:1219–22.

    CAS  Google Scholar 

  51. Takasugi J, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging. 1989;4:41–8.

    Article  PubMed  CAS  Google Scholar 

  52. Rapoport S, Blair D, McCarthy S, et al. Brachial plexus: correlation of MR imaging with CT and pathologic findings. Radiology. 1988;167:161–5.

    PubMed  CAS  Google Scholar 

  53. Blair D, Rapoport S, Sostman H. Normal brachial plexus: MR imaging. Radiology. 1987;165:763–7.

    PubMed  CAS  Google Scholar 

  54. Freundlich I, Chasen M, Dalla G. Magnetic resonance imaging of pulmonary apical tumors. J Thorac Imaging. 1996;11:210–22.

    PubMed  CAS  Google Scholar 

  55. Martini N, Heelan R, Westcott J. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg. 1985;90:639–48.

    PubMed  CAS  Google Scholar 

  56. Glazer H, Duncan-Meyer J, Aronberg D. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology. 1985;157:191–4.

    PubMed  CAS  Google Scholar 

  57. De Wever W, Stroobants S, Coolen J, et al. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration. Eur Respir J. 2009;33:201–12.

    Article  PubMed  Google Scholar 

  58. Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4:568–577.

    Google Scholar 

  59. Glazer G, Gross B, Quint L, et al. Normal mediastinal lymph nodes: number and size according to American thoracic society mapping. Am J Roentgenol. 1985;144:261–5.

    CAS  Google Scholar 

  60. Quint L, Glazer G, Orringer M, et al. Mediastinal lymph node detection and sizing at CT and autopsy. Am J Roentgenol. 1986;147:469–72.

    CAS  Google Scholar 

  61. Genereux G, Howie J. Normal mediastinal lymph node size and number: CT and anatomic study. Am J Roentgenol. 1984;142:1095–100.

    CAS  Google Scholar 

  62. Schnyder P, Gamsu G. CT of the pretracheal retrocaval space. Am J Roentgenol. 1981;136:303–8.

    CAS  Google Scholar 

  63. Kiyono K, Sone S, Sakai F. The number and size of normal mediastinal lymph nodes: a postmortem study. Am J Roentgenol. 1988;150:771–6.

    CAS  Google Scholar 

  64. Glazer G, Orringer M, Gross B, Quint L. The mediastinum in non-small cell lung cancer: CT-surgical correlation. Am J Roentgenol. 1984;142:1101–5.

    CAS  Google Scholar 

  65. Platt J, Glazer G, Gross B, Quint L, Francis I, Orringer M. CT evaluation of mediastinal lymph nodes in lung cancer: influence of the lobar site of the primary neoplasm. Am J Roentgenol. 1987;149:683–6.

    CAS  Google Scholar 

  66. Faling L, Pugatch R, Jung-Legg Y. Computed tomographic scanning of the mediastinum in the staging of bronchogenic carcinoma. Am Rev Respir Dis. 1981;124:690–5.

    PubMed  CAS  Google Scholar 

  67. Baron R, Levitt R, Sagel S, et al. Computed tomography in the preoperative evaluation of bronchogenic carcinoma. Radiology. 1982;145:727–32.

    PubMed  CAS  Google Scholar 

  68. Mouk G, Cockerill E, Farber M, et al. Computed tomography vs standard radiology in the evaluation of mediastinal adenopathy. Chest. 1982;82:69–75.

    Article  Google Scholar 

  69. Osborne D, Korobkin M, Ravin C. Comparison of plain radiography conventional tomography, and computed tomography in detecting intrathoracic lymph node metastases from lung carcinoma. Radiology. 1982;142:157–61.

    PubMed  CAS  Google Scholar 

  70. Rea H, Shevland J, House A. Accuracy of computed tomographic scanning in assessment of the mediastinum in bronchial carcinoma. Thorac Cardiovasc Surg. 1981;81:825–9.

    CAS  Google Scholar 

  71. Buy J, Ghossain M, Poirson F. Computed tomography of mediastinal lymph nodes in nonsmall cell lung cancer. J Comput Assist Tomogr. 1988;12:545–52.

    Article  PubMed  CAS  Google Scholar 

  72. Ikezoe J, Kadowaki K, Morimoto S. Mediastinal lymph node metastases from nonsmall cell bronchogenic carcinoma: reevaluation with CT. J Comput Assist Tomogr. 1990;14:340–4.

    Article  PubMed  CAS  Google Scholar 

  73. Izbicki J, Thetter O, Karg O. Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. J Thorac Cardiovasc Surg. 1992;104:413–20.

    PubMed  CAS  Google Scholar 

  74. Dales R, Stark R, Raman S. Computed tomography to stage lung cancer. Am Rev Respir Dis. 1990;144:1096–101.

    Google Scholar 

  75. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from Non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology. 1999;213:530–6.

    PubMed  CAS  Google Scholar 

  76. Erasmus JJ, McAdams HP, Patz EF. Non-small cell lung cancer: FDG-PET imaging. J Thorac Imaging. 1999;14:247–56.

    Article  PubMed  CAS  Google Scholar 

  77. Pfister DG, Johnson DH, Azzoli CG. American society of clinical oncology treatment of unresectable non-small-cell Lung cancer guideline: update 2003. J ClinOncol. 2004; 22:330–353.

    Google Scholar 

  78. Lee BE, von Haag D, Lown T, et al. Advances in positron emission tomography technology have increased the need for surgical staging in non–small cell lung cancer. J Thorac Cardiovasc Surg. 2007;133:746–52.

    Article  PubMed  Google Scholar 

  79. de Langen AJ, Raijmakers P, Riphagen I, et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg. 2006;29:26–9.

    Article  PubMed  Google Scholar 

  80. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229:526–33.

    Article  PubMed  Google Scholar 

  81. Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 1996;62:246–50.

    Article  PubMed  CAS  Google Scholar 

  82. Murayama S, Murakami J, Yoshimitsu K, et al. CT diagnosis of pleural dissemination without pleural effusion in primary lung cancer. Radiat Med. 1996;14:117–9.

    PubMed  CAS  Google Scholar 

  83. Truong MT, Viswanathan C, Erasmus JJ. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging. 2011;26:132–46.

    Article  PubMed  Google Scholar 

  84. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med. 2000;27:1441–56.

    Article  PubMed  CAS  Google Scholar 

  85. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg. 1995;60:1573–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of South Florida College of Medicine, 2 Tampa General Circle, STC 6072, Tampa, FL, 33606-3571, USA

    Todd R. Hazelton

  2. Department of Internal Medicine, Division of Pulmonary/Critical Care Medicine, USF College of Medicine, 12902 Magnolia Drive, Tampa, FL, 33612, USA

    Frank W. Walsh

  3. Moffitt Cancer Center, Tampa, FL, USA

    Frank W. Walsh

Authors
  1. Todd R. Hazelton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank W. Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd R. Hazelton .

Editor information

Editors and Affiliations

  1. , Cardiothoracic Radiology, University of Wisconsin Hospital and Cli, 600 Highland Ave., Madison, 53792, USA

    Jeffrey P. Kanne

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hazelton, T.R., Walsh, F.W. (2012). Lung Cancer. In: Kanne, J. (eds) Clinically Oriented Pulmonary Imaging. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-542-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-542-8_3

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-541-1

  • Online ISBN: 978-1-61779-542-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation